Cite
HARVARD Citation
Marchetti, C. et al. (2015). Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386). Critical reviews in oncology/hematology. 94 (3), pp. 302-310. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Marchetti, C. et al. (2015). Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386). Critical reviews in oncology/hematology. 94 (3), pp. 302-310. [Online].